Ocugen, Inc. — Director's Dealing 2021

Apr 29, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Ocugen, Inc. (OCGN)
CIK: 0001372299
Period of Report: 2021-04-26

Reporting Person: Kompella Uday (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-04-26	Common Stock	S	350000	$11.7	Disposed	600674	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	479416	Indirect

Footnotes

F1: This sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $10.8300 to $12.5400.